Barclays’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.68M | Sell |
|
|||||
|
2025
Q2 | $1.45M | Buy |
|
|||||
|
2025
Q1 | $464K | Sell |
|
|||||
|
2024
Q4 | $704K | Buy |
|
|||||
|
2024
Q3 | $529K | Buy |
|
|||||
|
2024
Q2 | $147K | Sell |
|
|||||
|
2024
Q1 | $404K | Sell |
|
|||||
|
2023
Q4 | $925K | Buy |
|
|||||
|
2023
Q3 | $201K | Sell |
|
|||||
|
2023
Q2 | $298K | Sell |
|
|||||
|
2023
Q1 | $397K | Buy |
|
|||||
|
2022
Q4 | $265K | Buy |
|
|||||
|
2022
Q3 | $114K | Sell |
|
|||||
|
2022
Q2 | $190K | Sell |
|
|||||
|
2022
Q1 | $274K | Sell |
|
|||||
|
2021
Q4 | $1.04M | Buy |
|
|||||
|
2021
Q3 | $435K | Buy |
|
|||||
|
2021
Q2 | $100K | Sell |
|
|||||
|
2021
Q1 | $1.05M | Buy |
|
|||||
|
2020
Q4 | $464K | Sell |
|
|||||
|
2020
Q3 | $637K | Sell |
|
|||||
|
2020
Q2 | $1.5M | Buy |
|
|||||
|
2020
Q1 | $1M | Sell |
|
|||||
|
2019
Q4 | $1.42M | Buy |
|
|||||
|
2019
Q3 | $879K | Sell |
|
|||||
|
2019
Q2 | $1.8M | Buy |
|
|||||
|
2019
Q1 | $1M | Buy |
|
|||||
|
2018
Q4 | $481K | Sell |
|
|||||
|
2018
Q3 | $1.03M | Buy |
|
|||||
|
2018
Q2 | $72K | Sell |
|
|||||
|
2018
Q1 | $286K | Buy |
|
|||||
|
2017
Q4 | $248K | Buy |
|
|||||
|
2017
Q3 | $79K | Buy |
|
|||||
|
2017
Q2 | $71K | Sell |
|
|||||
|
2017
Q1 | $607K | Buy |
|
|||||
|
2016
Q4 | $115K | Buy |
|
|||||
|
2016
Q3 | $71K | Sell |
|
|||||
|
2016
Q2 | $305K | Buy |
|
|||||
|
2016
Q1 | $7K | Sell |
|
|||||
|
2015
Q4 | $113K | Sell |
|
|||||
|
2015
Q3 | $90K | Buy |
|
|||||
|
2015
Q2 | $7K | Sell |
|
|||||
|
2015
Q1 | $19K | Sell |
|
|||||
|
2014
Q4 | $59K | Buy |
|
|||||
|
2014
Q3 | $80K | Sell |
|
|||||
|
2014
Q2 | $220K | Buy |
|